منابع مشابه
Recurrence of borderline ovarian tumors.
AIM To increase the efficiency of diagnosis and treatment of patients with recurrences of borderline ovarian tumors (BOT). MATERIALS AND METHODS 106 patients with BOT of stage I have been treated and clinically observed: the I group (82 patients, mean age -- 38.9 ± 5.5 years), who were treated with standard surgical operation (panhysterectomy); the II group (24 patients, mean age -- 30.3 ± 5....
متن کاملMRI appearances of pure epithelial papillary serous borderline ovarian tumours.
Borderline epithelial ovarian tumours (BOT) represent 15-20% of all non-benign ovarian epithelial neoplasms. Compared to malignant ovarian tumours, they usually present at a younger age and carry a far superior prognosis. Fertility-conserving surgery is an important treatment option for patients with BOT. Ultrasound and CT are both widely available and play roles in the initial investigation an...
متن کاملdiagnostic relevance of agnor in ovarian serous borderline tumors
nucleolar organizer regions are loops a/nuclear dna related to ribosomal dna, and their number in cells is believed to indicate cellular proliferative activity. using_a silver staining methodto visualize thesestructures inparaffin embeddedtissue sections, an attempt was made to determine ifthese agnor counts could be used as a diagnostic toolfor serous borderline tumors of the ovary. ten cases ...
متن کاملA clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
OBJECTIVE To evaluate the risk factors associated with recurrence of borderline ovarian tumors that may be used as evidence of the efficacy of select preventive procedures. METHODS Various clinicopathologic factors of 234 patients with borderline ovarian tumors admitted to our hospital between January 2001 and June 2007 were reviewed. Univariate and multivariate logistic regression models wer...
متن کاملSecond primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.
The role of serous borderline ovarian tumors (BOTs) in the pathogenesis of serous ovarian carcinomas is unclear. Some authors have compared mutations in serous BOTs to those in serous ovarian carcinomas, but the data on two common oncogenes, p53 and K-ras, remain inconclusive. To further clarify the relationship between the two tumors, we performed mutational analysis on tumors from a set of ei...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gynecological Surgery
سال: 2006
ISSN: 1613-2076,1613-2084
DOI: 10.1007/s10397-005-0146-0